Atrial Fibrillation Among ICU Patients with Type 2 Respiratory Failure: Who Is at Risk and What Are the Outcomes?
Rattachement africain : tr. Niveau de preuve : code pays fourni par la source.
Le résumé fourni par la source
Background: Atrial fibrillation (AF) is commonly seen in patients with hypercapnic type 2 respiratory failure and may negatively impact prognosis. This study aimed to evaluate the clinical characteristics and prognostic implications of AF in patients admitted to the intensive care unit (ICU) with hypercapnic type 2 respiratory failure. Methods: In this retrospective single-center study, 200 adult patients diagnosed with hypercapnic type 2 respiratory failure between May 2022 and May 2023 were included. Patients were categorized based on the presence of AF. Demographic, laboratory, and echocardiographic findings, comorbidities, and outcomes were compared. Kaplan–Meier survival analysis and Cox regression were used to identify mortality predictors. Results: AF was present in 50.5% of patients. Those with AF were older, had higher Charlson Comorbidity Index scores, and a greater prevalence of heart failure (p<0.001). No significant differences were found in arterial blood gas values. AF patients had higher urea, creatinine, and BNP levels, and lower hemoglobin, lymphocyte, eosinophil, and monocyte counts (p<0.05). Echocardiography showed more severe tricuspid and mitral regurgitation, lower ejection fractions, and higher systolic pulmonary pressures in the AF group. About 20% of AF patients were not receiving anticoagulants at ICU admission. AF was associated with shorter survival (49.6±4.07 vs. 61.4±3.8 days, p = 0.031) and 1.6-fold higher mortality risk (HR: 1.60, 95% CI: 1.04–2.47). Advanced age and low hemoglobin were independent predictors of mortality. Conclusion: AF is frequent among patients with type 2 respiratory failure and is linked to increased mortality. Despite known complications, treatment remains underutilized. AF should be actively screened during ICU admissions for respiratory failure.
Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.
Le contrôle bibliographique ouvert
DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.
- Titre Crossref
- Atrial Fibrillation Among ICU Patients with Type 2 Respiratory Failure: Who Is at Risk and What Are the Outcomes?
- Date Crossref
- 03/06/2025
- Éditeur
- MDPI AG
- Type
- posted-content
Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude, et il ne compte pas comme une seconde source scientifique indépendante.
Où se fait cette recherche
-
Gülhane Askerî Tıp Akademisi pays non établi dans la noticeÉtablissement de santé
-
Ankara Atatürk Eğitim ve Araştırma Hastanesi pays non établi dans la noticeÉtablissement de santé
-
Alanya University pays non établi dans la noticeUniversité ou école supérieure
-
Konya Eğitim ve Araştırma Hastanesi pays non établi dans la noticeÉtablissement de santé
-
Farabi Hastanesi pays non établi dans la noticeÉtablissement de santé
-
Ankara University pays non établi dans la noticeUniversité ou école supérieure
-
Sağlık Bilimleri Üniversitesi pays non établi dans la noticeUniversité ou école supérieure
-
Memorial Ankara Hospital pays non établi dans la noticeÉtablissement de santé
-
Atatürk Sanatorium Research Hospital Department of Anesthesiology pays non établi dans la noticeÉtablissement de santé
-
Gulhane Training and Research Hospital pays non établi dans la noticeÉtablissement de santé
-
Alanya Alaaddin Keykubat University pays non établi dans la noticeUniversité ou école supérieure
-
Konya Farabi Hospital pays non établi dans la noticeÉtablissement de santé
Gülhane Askerî Tıp Akademisi, Ankara Atatürk Eğitim ve Araştırma Hastanesi et Alanya University, avec 9 autres affiliations.
Une affiliation ne permet pas de déduire la nationalité d’un auteur.